SWOG Cancer Research Network’s mission is to improve the practice of cancer medicine in preventing, detecting, and treating cancer, and to enhance the quality of life for cancer survivors, primarily through design and conduct of clinical trials. SWOG is a National Cancer Institute-supported network of cancer researchers at more than 1,300 sites in the U.S., Canada, and beyond. Additional educational and cancer research support is provided by SWOG’s non-profit philanthropic partner, The Hope Foundation for Cancer Research.
The SWOG/Hope Foundation Impact Award is a funding program from The Hope Foundation that encourages novel and innovative SWOG research by supporting early and conceptual stages of these projects. The work proposed should use resources from completed SWOG trials or be directly translatable to clinical trials in SWOG and the NCTN in the foreseeable future.
Awards are issued through a competitive peer-review process that includes SWOG and Hope Foundation leaders as well as externally nominated reviewers, as necessary.
Individual projects are funded for up to $250,000 (total cost) and may be spent over a 2-year award period. Funding for smaller feasibility projects that are critical to the conduct of future SWOG trials are also encouraged. Indirect costs are included in the total award and limited to a rate of 25%. The number of awards and duration of program is contingent upon available funding at SWOG and The Hope Foundation.
KEY DATES LOI Deadline: January 15 at 5pm ET Full Application Deadline: Determined upon invitation Award Period: June 1-May 31
Core mission: Increase participation of underrepresented groups in STEM graduate education.
Top success predictors
Clear STEM degree trajectory (MS/PhD) with strong academic preparation
Compelling personal statement linking background, barriers, and STEM goals
Demonstrated commitment to diversity, equity, and inclusion (mentoring, outreach, service)
Well-defined career plan showing long-term impact in STEM
Strong letters of recommendation emphasizing resilience, leadership, and research potential
Common pitfalls
Generic DEI statements without concrete examples
Weak alignment between proposed field and long-term goals
Core mission: Support innovative research to prevent, treat, and manage heart disease (UK-focused).
Top success predictors
Clear translational relevance to cardiovascular disease outcomes
Innovative but feasible pilot-scale studies
Strong methodology and statistics, appropriate to limited budgets
Early-career investigator leadership with senior mentorship
Clear plan for next-step funding (NIHR/MRC/BHF)
Common pitfalls
Overambitious scope for grant size
Weak clinical relevance or unclear patient benefit
Core mission: Advance research and training in bleeding and clotting disorders.
Top success predictors
Direct relevance to hemostasis/thrombosis or rare bleeding disorders
Clear clinical or translational focus (bench-to-bedside favored)
Early-career investigator development (career development grants are key)
Strong mentorship and access to patient populations or registries
Practical, well-powered study design
Common pitfalls
Projects drifting into general hematology without a hemostasis focus
Insufficient mentorship structure
Core mission: Accelerate research on neurodegenerative diseases (Alzheimer’s, Parkinson’s, ALS, FTLD).
Top success predictors
High-risk / high-reward scientific ideas
Clear disease relevance with mechanistic insight
Strong PI creativity and independence (often early- to mid-career)
Concise, elegant experimental plans
Potential to generate transformative insights, not incremental work
Common pitfalls
Incremental extensions of existing projects
Weak justification of novelty or disease relevance
Core mission: Support early-career investigators and innovative cancer research.
Top success predictors
Early-career PI with strong upward trajectory
Innovative hypothesis with clear translational relevance
Focused aims achievable within short funding period
Strong mentorship and institutional support
Clear path to NIH or major foundation follow-on funding
Common pitfalls
Overly descriptive or exploratory proposals
Lack of long-term vision beyond the pilot project
Across these programs, funded applications consistently show:
Clear mission alignment (this matters more than prestige)
Feasible scope matched to modest grant sizes
Strong narrative linking people → problem → impact
Evidence the funding will be career- or field-changing, not just supportive
Any SWOG member investigator eligible for NIH funding is encouraged to submit to this program. Awardees will be expected to present their work at one or more semiannual SWOG group meetings and to adhere to Group policies and procedures as applicable to the project.
Sponsor Institute/Organizations: Hope Foundation for Cancer Research
Sponsor Type: Corporate/Non-Profit
Address: 24 Frank Lloyd Wright Drive P.O. Box 483 (Suite 4300K) Ann Arbor, Michigan 48105
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
LOI Deadline: January 15 at 5pm ET
Full Application Deadline: Determined upon invitation
Award Period: June 1-May 31
$250,000
Affiliation: Hope Foundation for Cancer Research
Address: 24 Frank Lloyd Wright Drive P.O. Box 483 (Suite 4300K) Ann Arbor, Michigan 48105
Website URL: https://thehopefoundation.org/funding-opportunities/swog-hope-foundation-impact-award/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.